BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2154819)

  • 1. [3H] beta-funaltrexamine ([3H] beta-FNA) binds irreversibly to mu opioid receptors in the rat brain: autoradiographic study.
    Liu-Chen LY; Li SX; Rohrbach KW; Lewis ME
    Prog Clin Biol Res; 1990; 328():61-4. PubMed ID: 2154819
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
    Tam SW; Liu-Chen LY
    J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
    Liu-Chen LY; Yang HH; Li S; Adams JU
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoradiographic study of irreversible binding of [3H]beta-funaltrexamine to opioid receptors in the rat forebrain: comparison with mu and delta receptor distribution.
    Liu-Chen LY; Li SX; Lewis ME
    Brain Res; 1991 Mar; 544(2):235-42. PubMed ID: 1645609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidence.
    Rothman RB; Long JB; Bykov V; Jacobson AE; Rice KC; Holaday JW
    J Pharmacol Exp Ther; 1988 Nov; 247(2):405-16. PubMed ID: 2846819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intracerebroventricular administration of beta-funaltrexamine on [3H]DAMGO binding to rat brain sections.
    Martin TJ; Dworkin SI; Smith JE
    J Pharmacol Exp Ther; 1993 Oct; 267(1):506-14. PubMed ID: 8229781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of beta-funaltrexamine with [3H]cycloFOXY binding in rat brain: further evidence that beta-FNA alkylates the opioid receptor complex.
    Rothman RB; Bykov V; Mahboubi A; Long JB; Jiang Q; Porreca F; de Costa BR; Jacobson AE; Rice KC; Holaday JW
    Synapse; 1991 Jun; 8(2):86-99. PubMed ID: 1652797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoradiographic localization of opioid receptor types in the rat small intestine.
    Dashwood MR; Sykes RM; Thompson CS
    NIDA Res Monogr; 1986; 75():315-8. PubMed ID: 2828980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intracerebroventricular beta-funaltrexamine on mu and delta opioid receptors in the rat: dichotomy between binding and antinociception.
    Liu-Chen LY; Li SX; Wheeler-Aceto H; Cowan A
    Eur J Pharmacol; 1991 Oct; 203(2):195-202. PubMed ID: 1666046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alkylation of mu opioid receptors by beta-funaltrexamine in vivo: comparison of the effects on in situ binding and heroin self-administration in rats.
    Martin TJ; Dworkin SI; Smith JE
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1135-40. PubMed ID: 7891326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mu/delta opioid site selectivity of some antidepressants.
    Codd EE; Walker RF
    NIDA Res Monogr; 1986; 75():351-4. PubMed ID: 2828984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of [125I]beta-endorphin binding to rat brain and NG108-15 cells using a monoclonal antibody directed against the opioid receptor.
    Bidlack JM; O'Malley WE; Schulz R
    Mol Pharmacol; 1988 Feb; 33(2):170-7. PubMed ID: 2828912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intracerebroventricular administration of beta-funaltrexamine on DAMGO-stimulated [35S]GTP-gamma-S binding in rat brain sections.
    Martin TJ; Sim LJ; Selley DE; deMontis MG; Childers SR
    Synapse; 1997 Nov; 27(3):177-82. PubMed ID: 9329153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding characteristics of [D-Ala2-MePhe4-Glyol5] enkephalin and [D-Pen2,D-Pen5] enkephalin in rat brain: inhibition studies with fentanyl-like drugs.
    Yeadon M; Kitchen I
    NIDA Res Monogr; 1986; 75():64-6. PubMed ID: 2829008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stress prevents the chronic ethanol-induced delta opiod receptor supersensitivity in the rat brain.
    Przewłocka B; Lasoń W
    Pol J Pharmacol Pharm; 1990; 42(2):137-42. PubMed ID: 2177189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of mu, delta and kappa binding sites in rat brain revealed by quantitative autoradiography.
    Morris BJ; Millan MJ; Herz A
    J Pharmacol Exp Ther; 1988 Nov; 247(2):729-36. PubMed ID: 2846828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral effects of opioid peptides selective for mu or delta receptors. II. Locomotor activity in nondependent and morphine-dependent rats.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):997-1003. PubMed ID: 3018231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system.
    Tao R; Auerbach SB
    J Pharmacol Exp Ther; 2002 Nov; 303(2):549-56. PubMed ID: 12388635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Light microscopic autoradiographic localization of delta opioid receptors in the rat brain using a highly selective bis-penicillamine cyclic enkephalin analog.
    Gulya K; Gehlert DR; Wamsley JK; Mosberg H; Hruby VJ; Yamamura HI
    J Pharmacol Exp Ther; 1986 Aug; 238(2):720-6. PubMed ID: 3016247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.